Ondine Biomedical Inc. announces that Mater Hospital, North Sydney, a private hospital in New South Wales, has become the first Australian hospital to start using its light-activated antimicrobial Steriwave® technology to prevent the spread of hospital-acquired infections (HAIs). Mater Hospital, located in North Sydney and founded in 1906, is part of St. Vincent's Health Australia Group, Australia's largest not-for-profit provider of health and aged care services.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7 GBX | 0.00% | +36.59% | -20.00% |
05-08 | Hellenic Dynamics and Ondine Biomedical raise funds | AN |
05-03 | Ondine Biomedical shares rise on fundraise to advance Steriwave | AN |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.00% | 19.83M | |
-4.66% | 183B | |
-1.01% | 108B | |
-4.20% | 67.51B | |
+2.68% | 50.67B | |
+9.12% | 44.7B | |
+3.21% | 40.95B | |
+4.13% | 26.71B | |
+3.31% | 26.8B | |
+13.35% | 24.62B |
- Stock Market
- Equities
- OBI Stock
- News Ondine Biomedical Inc.
- Mater Hospital, to Use Ondine Biomedical's Award-Winning Light-Activated Antimicrobial Technology